154 related articles for article (PubMed ID: 29364965)
1. Correction: Comparison of the Predicted Population Coverage of Tuberculosis Vaccine Candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a Bioinformatics Approach.
Davila J; McNamara LA; Yang Z
PLoS One; 2012; 7(10):. PubMed ID: 29364965
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the predicted population coverage of tuberculosis vaccine candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a bioinformatics approach.
Davila J; McNamara LA; Yang Z
PLoS One; 2012; 7(7):e40882. PubMed ID: 22815851
[TBL] [Abstract][Full Text] [Related]
3. Chimaeric protein improved immunogenicity compared with fusion protein of Ag85B and ESAT-6 antigens of Mycobacterium tuberculosis.
Xu Y; Wang B; Chen J; Wang Q; Zhu B; Shen H; Qie Y; Wang J; Wang H
Scand J Immunol; 2006 Nov; 64(5):476-81. PubMed ID: 17032239
[TBL] [Abstract][Full Text] [Related]
4. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6.
Langermans JA; Doherty TM; Vervenne RA; van der Laan T; Lyashchenko K; Greenwald R; Agger EM; Aagaard C; Weiler H; van Soolingen D; Dalemans W; Thomas AW; Andersen P
Vaccine; 2005 Apr; 23(21):2740-50. PubMed ID: 15780721
[TBL] [Abstract][Full Text] [Related]
5. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P
Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467
[TBL] [Abstract][Full Text] [Related]
6. [The effect of various antigen compounds of tuberculosis composite antigen vaccine on the immune function in mice].
Wang P; Xu M; Chen BW; DU WX; Yang L; Jing SR; Wang GZ
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Apr; 34(4):269-73. PubMed ID: 21609610
[TBL] [Abstract][Full Text] [Related]
7. The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: a randomized controlled phase I/II study.
Spertini F; Audran R; Lurati F; Ofori-Anyinam O; Zysset F; Vandepapelière P; Moris P; Demoitié MA; Mettens P; Vinals C; Vastiau I; Jongert E; Cohen J; Ballou WR
Tuberculosis (Edinb); 2013 Mar; 93(2):179-88. PubMed ID: 23219236
[TBL] [Abstract][Full Text] [Related]
8. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
[TBL] [Abstract][Full Text] [Related]
9. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
10. Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31.
Agger EM; Rosenkrands I; Olsen AW; Hatch G; Williams A; Kritsch C; Lingnau K; von Gabain A; Andersen CS; Korsholm KS; Andersen P
Vaccine; 2006 Jun; 24(26):5452-60. PubMed ID: 16675077
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Ag85B vaccine by taking advantage of characteristics of human parainfluenza type 2 virus vector showed Mycobacteria-specific immune responses by intranasal immunization.
Watanabe K; Matsubara A; Kawano M; Mizuno S; Okamura T; Tsujimura Y; Inada H; Nosaka T; Matsuo K; Yasutomi Y
Vaccine; 2014 Mar; 32(15):1727-35. PubMed ID: 24486310
[TBL] [Abstract][Full Text] [Related]
12. The Ag85B protein of the BCG vaccine facilitates macrophage uptake but is dispensable for protection against aerosol Mycobacterium tuberculosis infection.
Prendergast KA; Counoupas C; Leotta L; Eto C; Bitter W; Winter N; Triccas JA
Vaccine; 2016 May; 34(23):2608-15. PubMed ID: 27060378
[TBL] [Abstract][Full Text] [Related]
13. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
Luo XD; Zhu DY; Chen Q; Jiang Y; Jiang S; Yang C
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):611-6. PubMed ID: 15498274
[TBL] [Abstract][Full Text] [Related]
14. The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants.
Chen L; Xu M; Wang ZY; Chen BW; Du WX; Su C; Shen XB; Zhao AH; Dong N; Wang YJ; Wang GZ
FEMS Immunol Med Microbiol; 2010 Jun; 59(1):42-52. PubMed ID: 20298499
[TBL] [Abstract][Full Text] [Related]
15. Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant.
Kamath AT; Rochat AF; Valenti MP; Agger EM; Lingnau K; Andersen P; Lambert PH; Siegrist CA
PLoS One; 2008; 3(11):e3683. PubMed ID: 18997860
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
[TBL] [Abstract][Full Text] [Related]
17. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
[TBL] [Abstract][Full Text] [Related]
18. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X
Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431
[TBL] [Abstract][Full Text] [Related]
19. [Constructing shuttle plasmid fusion expressing Ag85B-ESAT-6 on the surface of Mycobacterium].
Shi CH; Fan XL; Shi JR; Xu ZK; Li Y; Bai YN; Xun Y
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):249-52. PubMed ID: 15144616
[TBL] [Abstract][Full Text] [Related]
20. Novel recombinant BCG coexpressing Ag85B, ESAT-6 and Rv2608 elicits significantly enhanced cellular immune and antibody responses in C57BL/6 mice.
Lu Y; Xu Y; Yang E; Wang C; Wang H; Shen H
Scand J Immunol; 2012 Sep; 76(3):271-7. PubMed ID: 22671973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
